Seroreactivity to human papillomavirus (HPV) types 16, 18, or 31 and risk of subsequent HPV infection: results from a population-based study in Costa Rica.
D000328:Adult; D000914:Antibodies, Viral / Q000032:analysis; D000917:Antibody Formation; D015331:Cohort Studies; D003364:Costa Rica; D005260:Female; D006801:Humans; D027383:Papillomaviridae / Q000145:classification / Q000235:genetics / Q000472:pathogenicity*; D030361:Papillomavirus Infections / Q000209:etiology*; D016133:Polymerase Chain Reaction; D018570:Risk Assessment; D016036:Seroepidemiologic Studies; D012698:Serologic Tests
D000914:Antibodies, Viral